With an aim to discover new therapeutic targets for EMs, we delineated in the present study a novel mechanism, by which miR-30c attenuated the biological phenotypes of ecto-EECs by blocking the BCL9/Wnt/CD44 regulatory axis in O-EMs. This evidence concerns the gene BCL9 and eosinophilia-myalgia syndrome.